High Mobility Group-I(Y) Protein Facilitates Nuclear Factor-κB Binding and Transactivation of the Inducible Nitric-oxide Synthase Promoter/Enhancer*

Nitric oxide (NO), a free radical gas whose production is catalyzed by the enzyme NO synthase, participates in the regulation of multiple organ systems. The inducible isoform of NO synthase (iNOS) is transcriptionally up-regulated by inflammatory stimuli; a critical mediator of this process is nuclear factor (NF)-κB. Our objective was to determine which regulatory elements other than NF-κB binding sites are important for activation of the iNOS promoter/enhancer. We also wanted to identify transcription factors that may be functioning in conjunction with NF-κB (subunits p50 and p65) to drive iNOS transcription. Deletion analysis of the iNOS promoter/enhancer revealed that an AT-rich sequence (−61 to −54) downstream of the NF-κB site (−85 to −76) in the 5′-flanking sequence was important for iNOS induction by interleukin-1β and endotoxin in vascular smooth muscle cells. This AT-rich sequence, corresponding to an octamer (Oct) binding site, bound the architectural transcription factor high mobility group (HMG)-I(Y) protein. Electrophoretic mobility shift assays showed that HMG-I(Y) and NF-κB subunit p50 bound to the iNOS promoter/enhancer to form a ternary complex. The formation of this complex required HMG-I(Y) binding at the Oct site. The location of an HMG-I(Y) binding site typically overlaps that of a recruited transcription factor. In the iNOS promoter/enhancer, however, HMG-I(Y) formed a complex with p50 while binding downstream of the NF-κB site. Furthermore, overexpression of HMG-I(Y) potentiated iNOS promoter/enhancer activity by p50 and p65 in transfection experiments, suggesting that HMG-I(Y) contributes to the transactivation of iNOS by NF-κB.

[1]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[2]  J. Paulauskis,et al.  Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase. , 1999, The Journal of biological chemistry.

[3]  Hong Wang,et al.  Enhancement of Serum-response Factor-dependent Transcription and DNA Binding by the Architectural Transcription Factor HMG-I(Y)* , 1998, The Journal of Biological Chemistry.

[4]  T. Maniatis,et al.  The mechanism of transcriptional synergy of an in vitro assembled interferon-beta enhanceosome. , 1997, Molecular cell.

[5]  Q. Xie A Novel Lipopolysaccharide-response Element Contributes to Induction of Nitric Oxide Synthase* , 1997, The Journal of Biological Chemistry.

[6]  W. Murphy,et al.  IL-6 induction of protein-DNA complexes via a novel regulatory region of the inducible nitric oxide synthase gene promoter: role of octamer binding proteins. , 1997, Journal of immunology.

[7]  M. Rosenfeld,et al.  POU domain family values: flexibility, partnerships, and developmental codes. , 1997, Genes & development.

[8]  T. Parmely,et al.  An Interferon-γ-activated Site (GAS) Is Necessary for Full Expression of the Mouse iNOS Gene in Response to Interferon-γ and Lipopolysaccharide* , 1997, The Journal of Biological Chemistry.

[9]  C. Patterson,et al.  Suppression of Interleukin-1β-induced Nitric-oxide Synthase Promoter/Enhancer Activity by Transforming Growth Factor-β1 in Vascular Smooth Muscle Cells , 1996, The Journal of Biological Chemistry.

[10]  C. Goldring,et al.  In vivo footprinting of the mouse inducible nitric oxide synthase gene: inducible protein occupation of numerous sites including Oct and NF-IL6. , 1996, Nucleic acids research.

[11]  D. Stuehr,et al.  Intracellular Assembly of Inducible NO Synthase Is Limited by Nitric Oxide-mediated Changes in Heme Insertion and Availability , 1996, The Journal of Biological Chemistry.

[12]  Dimitris Thanos,et al.  Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y) , 1995, Cell.

[13]  T. Maniatis,et al.  Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome , 1995, Cell.

[14]  P. Robbins,et al.  Expression of human inducible nitric oxide synthase in a tetrahydrobiopterin (H4B)-deficient cell line: H4B promotes assembly of enzyme subunits into an active dimer. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[15]  M. Wegner,et al.  Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y , 1995, Molecular and cellular biology.

[16]  C. Patterson,et al.  The ATF site mediates downregulation of the cyclin A gene during contact inhibition in vascular endothelial cells , 1995, Molecular and cellular biology.

[17]  T. Maniatis,et al.  Identification of the rel family members required for virus induction of the human beta interferon gene , 1995, Molecular and cellular biology.

[18]  Carl Nathan,et al.  Nitric oxide synthases: Roles, tolls, and controls , 1994, Cell.

[19]  C. Nathan,et al.  Role of interferon regulatory factor 1 in induction of nitric oxide synthase , 1994, The Journal of experimental medicine.

[20]  J. Tsai,et al.  Transforming growth factor-beta 1, but not dexamethasone, down-regulates nitric-oxide synthase mRNA after its induction by interleukin-1 beta in rat smooth muscle cells. , 1994, The Journal of biological chemistry.

[21]  R Grosschedl,et al.  HMG domain proteins: architectural elements in the assembly of nucleoprotein structures. , 1994, Trends in genetics : TIG.

[22]  C. Nathan,et al.  Role of transcription factor NF-kappa B/Rel in induction of nitric oxide synthase. , 1994, The Journal of biological chemistry.

[23]  S. Snyder,et al.  Macrophage nitric oxide synthase gene: two upstream regions mediate induction by interferon gamma and lipopolysaccharide. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[24]  T. Maniatis,et al.  Mechanisms of transcriptional synergism between distinct virus-inducible enhancer elements , 1993, Cell.

[25]  R. Eddy,et al.  Structural organization and chromosomal assignment of the gene encoding the human heparin-binding epidermal growth factor-like growth factor/diphtheria toxin receptor. , 1993, Biochemistry.

[26]  Y. Vodovotz,et al.  Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta , 1993, The Journal of experimental medicine.

[27]  C. Nathan,et al.  Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide , 1993, The Journal of experimental medicine.

[28]  J. Parrillo Pathogenetic mechanisms of septic shock. , 1993, The New England journal of medicine.

[29]  T. Tsuda,et al.  Cytokine‐induced expression of an inducible type of nitric oxide synthase gene in cultured vascular smooth muscle cells , 1993, FEBS letters.

[30]  N. Ishida,et al.  Cloning of inducible nitric oxide synthase in rat vascular smooth muscle cells. , 1993, Biochemical and biophysical research communications.

[31]  Dimitris Thanos,et al.  The High Mobility Group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene , 1992, Cell.

[32]  C. Nathan,et al.  Nitric oxide as a secretory product of mammalian cells , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  S. Snyder,et al.  Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[34]  G. Nolan,et al.  Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. , 1992, Genes & development.

[35]  Terry D. Lee,et al.  Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. , 1992, Science.

[36]  J. Cunningham,et al.  Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. , 1992, The Journal of biological chemistry.

[37]  R. Bone,et al.  The pathogenesis of sepsis. , 1991, Annals of internal medicine.

[38]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[39]  P. Baeuerle The inducible transcription activator NF-κB: regulation by distinct protein subunits , 1991 .

[40]  D. Landsman,et al.  Structural features of the HMG chromosomal proteins and their genes. , 1990, Biochimica et biophysica acta.

[41]  T. Quertermous,et al.  Functional analysis of the endothelin-1 gene promoter. Evidence for an endothelial cell-specific cis-acting sequence. , 1990, The Journal of biological chemistry.

[42]  M. Nissen,et al.  The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. A novel peptide motif for recognizing DNA structure. , 1990, The Journal of biological chemistry.

[43]  M. Birnstiel,et al.  Cloning of cDNAs coding for human HMG I and HMG Y proteins: both are capable of binding to the octamer sequence motif. , 1989, Nucleic acids research.

[44]  M. Krasnow,et al.  Transcriptional activation and repression by Ultrabithorax proteins in cultured Drosophila cells , 1989, Cell.

[45]  R. Reeves,et al.  Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y). , 1988, The Journal of biological chemistry.

[46]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[47]  I. Dawid,et al.  Transient expression of genes introduced into cultured cells of Drosophila. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. Alexander,et al.  Functional angiotensin II receptors in cultured vascular smooth muscle cells , 1982, The Journal of cell biology.

[49]  I. Schneider,et al.  Cell lines derived from late embryonic stages of Drosophila melanogaster. , 1972, Journal of embryology and experimental morphology.

[50]  C. Nathan,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Inducible Nitric Oxide Synthase : What Difference Does It Make ? , 2013 .

[51]  C. Nathan,et al.  Nitric oxide and macrophage function. , 1997, Annual review of immunology.

[52]  R. Reeves,et al.  High-mobility-group chromosomal proteins: architectural components that facilitate chromatin function. , 1996, Progress in nucleic acid research and molecular biology.

[53]  L. Ignarro Biosynthesis and metabolism of endothelium-derived nitric oxide. , 1990, Annual review of pharmacology and toxicology.